-transparent.png){kind=logo}
OBJECTIVE To evaluate the use of high-dose busulfan (HDB) with autologous bone marrow transplantation (ABMT) in patients with myeloma. METHODS Fifteen patients received HDB (16 mg/kg), eight of whom received high-dose melphalan (HDM) but had experienced a short remission or progression-free interval. Two patients had received HDM on two previous occasions, one had no response to low-dose melphalan, and four had impaired renal function (edathamil clearance < 40 mL/min). All patients received induction chemotherapy before HDB. RESULTS Two patients were in complete remission (CR) after induction chemotherapy before HDB. Of the remaining 13 patients, four (31%) achieved CR and two (15%) achieved a partial remission for an overall response rate of 46%. There were three treatment-related deaths, but the toxicity was otherwise predictable and manageable. CONCLUSIONS In heavily pretreated patients, HDB results in a relatively high response rate. It can also be used safely in patients with renal impairment who are not suitable for HDM.
J Mansi, and
F da Costa, and
C Viner, and
I Judson, and
M Gore, and
D Cunningham
March 1999,
Bulletin du cancer,
J Mansi, and
F da Costa, and
C Viner, and
I Judson, and
M Gore, and
D Cunningham
October 2017,
Clinical lymphoma, myeloma & leukemia,
J Mansi, and
F da Costa, and
C Viner, and
I Judson, and
M Gore, and
D Cunningham
June 2004,
Cancer,
J Mansi, and
F da Costa, and
C Viner, and
I Judson, and
M Gore, and
D Cunningham
May 1991,
Bone marrow transplantation,
J Mansi, and
F da Costa, and
C Viner, and
I Judson, and
M Gore, and
D Cunningham
September 1989,
Annals of internal medicine,
J Mansi, and
F da Costa, and
C Viner, and
I Judson, and
M Gore, and
D Cunningham
June 2013,
International journal of clinical pharmacy,
J Mansi, and
F da Costa, and
C Viner, and
I Judson, and
M Gore, and
D Cunningham
August 2007,
Leukemia research,
J Mansi, and
F da Costa, and
C Viner, and
I Judson, and
M Gore, and
D Cunningham
June 1998,
Praxis,
J Mansi, and
F da Costa, and
C Viner, and
I Judson, and
M Gore, and
D Cunningham
April 1993,
Cancer research,
J Mansi, and
F da Costa, and
C Viner, and
I Judson, and
M Gore, and
D Cunningham
January 1989,
Cancer chemotherapy and pharmacology,
